Tenax Therapeutics, Inc.

Release Summary

Tenax Therapeutics, Inc. (NASDAQ: TENX), provided update on review of strategic alternatives, departure of CEO John Kelley and appointment of Interim CEO Michael Jebsen.

Tenax Therapeutics, Inc.